Qianhai Health Holdings Limited revised Group earnings guidance for the 2021 Interim Period. It is expected that the Group will record a net loss of approximately HKD 3.7 million, instead of a net loss of approximately HKD 10.6 million as disclosed in the Profit Warning Announcement. The expected net loss for the 2021 Interim Period was mainly due to (i) the decrease in the business activities of Group in both health-care business and electronic component products business owing to the impact of the prolonged outbreak of the novel coronavirus pandemic, thereby leading to a decrease in revenue by approximately 50% as compared to that of the corresponding period in 2020 (as disclosed in the Profit Warning Announcement); (ii) the recognition of provision for impairment of loss under the expected credit loss model on the trade receivables of approximately HKD 22 million, and (iii) partially offset by the expected gain from the Disposal (comprising among other, release of exchange reserves) of HKD 15.4 million.